https://scholars.lib.ntu.edu.tw/handle/123456789/575316
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | CHING-HUNG LIN | en_US |
dc.contributor.author | Tang C.-H. | en_US |
dc.date.accessioned | 2021-07-28T06:46:38Z | - |
dc.date.available | 2021-07-28T06:46:38Z | - |
dc.date.issued | 2018 | - |
dc.identifier.issn | 0167-6806 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052535365&doi=10.1007%2fs10549-018-4872-1&partnerID=40&md5=5ffa014c6f435222232b3c2dbe6a78ae | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/575316 | - |
dc.publisher | Springer New York LLC | - |
dc.relation.ispartof | Breast Cancer Research and Treatment | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | anthracycline; glucocorticoid; breast cancer; cancer chemotherapy; cancer classification; cancer survival; cancer therapy; dose response; drug use; human; Letter; overall survival; physician; priority journal; progression free survival; prospective study; selection bias | - |
dc.title | Rebuttal comments on “Glucocorticoids in breast cancer treatment: Real benefit or selection bias?” | en_US |
dc.type | letter | en |
dc.identifier.doi | 10.1007/s10549-018-4872-1 | - |
dc.identifier.pmid | 30073549 | - |
dc.identifier.scopus | 2-s2.0-85052535365 | - |
dc.relation.journalvolume | 172 | - |
dc.relation.journalissue | 1 | - |
item.openairetype | letter | - |
item.openairecristype | http://purl.org/coar/resource_type/c_0857 | - |
item.fulltext | no fulltext | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Medical Oncology-NTUCC | - |
crisitem.author.dept | Oncology-NTUH | - |
crisitem.author.orcid | 0000-0003-2403-4056 | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Cancer Center (NTUCC) | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。